CSO at Aculeus Therapeutics | Biotech consultant | Ex @harvardmed @danafarber @petermacCC | My tweets are my own
Melbourne, Victoria
Joined July 2015
- Tweets434
- Following440
- Followers185
- Likes3.7K
Geoff Matthews retweeted
Today in @Nature we report a new prime editing strategy that can rescue a common cause of many genetic diseases in a disease-agnostic manner. This approach converts a redundant endogenous tRNA into an optimized suppressor tRNA, enabling a single prime edit to rescue premature stop codons across different diseases.
(1/15)
drive.google.com/file/d/1bSv…
👎👎👎
Our Victorian Chapter, AAMRI VIC, was disappointed today to see the Vic Govt has reduced funding for medical research in the 24/25 Budget, despite Vic scientists leading the way in their research & contributions to the VIC economy. @BenCarrollMP aamri.org.au/news-events/med…👇
Geoff Matthews retweeted
WEHI's Dr Sarah Diepstraten spoke with @10NewsFirstMelb about the novel combination of two cancer drugs that has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML).
Watch the segment 👇
New hope has been provided for those diagnosed with acute myeloid leukemia after Melbourne researchers discovered a drug combination that can kill cancer cells | @WEHI_research
Really great science by the @WEHI_research team made possible by a great collaboration with #aculeustherapeutics leading to better patient outcomes
Punching high! 🥊 WEHI researchers discovered that a duo of existing cancer drugs – venetoclax and a STING agonist – can KO #AML. As famous boxer Muhammad Ali might say, this treatment ‘floats like a butterfly & STINGs like a bee’!
Read more 👉wehi.edu.au/news/one-two-pun…
🧵1/2
Geoff Matthews retweeted
📢JOB Alert📢The Petermac Translational Research Centres are looking for Immunology Lead Scientist! Great opportunity to coordinate and conduct multiple translational research projects with a focus on immune biomarkers.🔬 Applications close 22 Aug 2023.
careers.petermac.org/job/MEL…
Geoff Matthews retweeted
C0VID & excess deaths: The last 3 years have seen a very big increase in total deaths in the world.
As this analysis from The Economist shows, C0VID is responsible for basically all of it.
2022 worse than 2020
XS death rates still high in 2023
economist.com/graphic-detail…
Very proud to share latest work from Constantine Mitsiades lab, started during my time at @DanaFarber / @harvardmed .
nature.com/articles/s43018-0…
Geoff Matthews retweeted
The @JohnstoneLab are hiring! We are looking for a Bioinformatician/computational biologist to join our group. Transcription, chromatin biology and cancer immunology is our focus. Interested? Check out the position description @PeterMacRes @PeterMacCC
careers.petermac.org/job/MEL…
Second day of #SITC22, breakfasting at one of my old faves, Tatte, reading through the abstracts. Lots of good science to hear about.
Geoff Matthews retweeted
A novel tool helping immunologists understand T cells may be a game-changer for developing new therapies
#Adfeature with @BDBiosciences
Geoff Matthews retweeted
Nature research paper: Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL nature.com/articles/s41586-0…
RASA2 ablation in T cells boosts antigen sensitivity and long term function nature.com/articles/s41586-0…
Geoff Matthews retweeted
In the past half-dozen years, immunotherapy has become one of the hottest areas of cancer research, fundamentally changing the way the disease is treated in many patients.
blog.dana-farber.org/insight…
After managing to avoid COVID while everyone around us had it, 2 days of vacation care for my 8yo ended up with 3/4 of us now positive! Just waiting for it to be 4/4! 😩
KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patients | MedPage Today medpagetoday.com/meetingcove…
Geoff Matthews retweeted
Just out! Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma ascopubs.org/doi/abs/10.1200…
Incredible collaborative team did longitudinal, single cell phenotyping of renal cancer #CTCs in 2 pt cohorts! @DrRanaMcKay @DrChoueiri @ejasonabel
SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells | Nature Immunology nature.com/articles/s41590-0…
Great paper, Salmon et al! 👏
Absolutely rapt to see this paper come together and published @CD_AACR. Kudos to @Pilar_dominguez @todorovizabela and Jess Salmon for leading this work. Interactions between epigenetics and tumor immunology….. so incredibly interesting! @PeterMacRes